As US navigates a shifting landscape of trade policy under new administration, markets grappling with implications of ...
Entero Therapeutics, Inc. (Nasdaq: ENTO) ("Entero" or the "Company"), a clinical-stage biopharmaceutical company specializing in the development of ...
22hon MSN
Daniel Loeb’s Third Point hedge fund sold off its position in Apple in the fourth quarter, while boosting its holdings in ...
Kinsale Capital Group, Inc. (NYSE: KNSL) reported net income of $109.1 million, $4.68 per diluted share, for the fourth quarter of 2024 compared to $103.4 million, ...
Dan Loeb's Third Point hedge fund exited Bath & Body Works and entered a stake in Capital One, among Q4 trades. Read more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results